Comment: Dilution of Vancomycin for Intrathecal or Intraventricular Administration

Annals of Pharmacotherapy

Volumn 30, Issue 4, 1996, Pages 415-

  Aalfs, Rebecca l ^a   Connelly, Julie f ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; CENTRAL NERVOUS SYSTEM INFECTION; DILUTION; DRUG CEREBROSPINAL FLUID LEVEL; DRUG FORMULATION; HOSPITAL PHARMACY; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG CARRIERS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; SODIUM CHLORIDE; VANCOMYCIN;

EID: 0029967796     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809603000421     Document Type: Letter

References (6)

1. Luer MS, Hatton J. Vancomycin administration into the cerebrospinal fluid: a review. Ann Pharmacother 1993;27:912-21.
2. Suefert RJ, Blackmon P, Hudson W. Recommended procedures for the preparation of intrathecal dosing in the hospital pharmacy. Hosp Pharm 1990;25:849-51.
3. Pau AK, Smego RA, Fisher MA. Intraventricular vancomycin: observations of tolerance and pharmacokinetics in two infants with ventricular shunt infections. Pediatr Infect Dis 1986;5:93-6.
4. Swayne R, Rampling A, Newsom SWB. Intraventricular vancomycin for treatment of shunt-associated ventriculitis. J Antimicrob Chemother 1987;19:249-53.
5. Arroyo JC, Quindlen EA. Accumulation of vancomycin after intraventricular infusions. South Med J 1983;76:1554-5.
6. Hirsch BE, Amodoio M, Einzig AI, Halevy R, Soeiro R. Instillation of vancomycin into a cerebrospinal fluid reservoir to clear infection: pharmacokinetic considerations. J Infect Dis 1991;163:197-200.